Business Name: |
Juarez-Uribe Joel MD |
Contact Person: |
Joel Juarez-Uribe |
Address: |
374 H St # 101, Chula Vista, California 91910 |
Phone Number: |
(619) 421-1228 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Szkopiec Roman L MD - Chula Vista, CA 91910 Mafong Erick A MD - Chula Vista, CA 91910 Hudler Elizabeth MD - Chula Vista, CA 91910 Children's Medical Group-S Bay - Chula Vista, CA 91910 Gutierrez Daisy C MD - Chula Vista, CA 91910 Monahan David E MD - Chula Vista, CA 91910 Farris Reuben M MD - Chula Vista, CA 91910 Cepin Monica MD - Chula Vista, CA 91910 Delgnan William MD - Chula Vista, CA 91910 Mohler Christy MD - Chula Vista, CA 91910 Lynn Bethany R MD - Chula Vista, CA 91910 Sadeghi Mehrdad MD - Chula Vista, CA 91910 Madany George MD - Chula Vista, CA 91910 Waisman Norberto MD - Chula Vista, CA 91910 Violeta Curbelo Md - Chula Vista, CA 91910 Raeber Kirk J DO - Chula Vista, CA 91910 Garay Alan MD - Chula Vista, CA 91910 Otten Richard MD - Chula Vista, CA 91910 Jankiewicz Joseph MD - Chula Vista, CA 91910 Montoya Perry V MD - Chula Vista, CA 91910 |
The company Juarez-Uribe Joel MD provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Juarez-Uribe Joel MD, and the business now earns $500.000 to $999.999 per annum.
Juarez-Uribe Joel MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Juarez-Uribe Joel MD, please call Joel Juarez-Uribe with the phone number (619) 421-1228 or visit its single location at 374 H St # 101 in Chula Vista, California 91910.
The location of the single location can also be found using the coordinates 32.63352,-117.0802.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.